Interesting study by @DrPoddubnyy et al. looking into the efficacy of SEC on HLAB27 subtypes (post hoc analysis of SKIPPAIN trial) ➡ SEC effective for both HLAB27+ and - grps ➡ Significant response seen among HLAB27+ and HLAB27 homozygous pts @RheumNow #ACR21 abs0917 https://t.co/St37kdGY65